Publication | Closed Access
A 5-year, Randomized, Open-Label Safety Study of Latanoprost and Usual Care in Patients with Open-Angle Glaucoma or Ocular Hypertension
32
Citations
21
References
2008
Year
This 5-year study suggests that latanoprost as prescribed in 14 countries is a safe long-term treatment for patients with glaucoma and ocular hypertension.
| Year | Citations | |
|---|---|---|
Page 1
Page 1